These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10377207)

  • 1. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
    Dempsey OJ; Coutie WJ; Wilson AM; Williams P; Lipworth BJ
    Thorax; 1999 Jul; 54(7):614-7. PubMed ID: 10377207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
    Wilson AM; Clark DJ; McFarlane L; Lipworth BJ
    Eur J Clin Pharmacol; 1997; 53(1):33-7. PubMed ID: 9349927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ; Humphreys M; Coutie WJ; Lipworth BJ
    Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ; Grove A; Cargill RI; Lipworth BJ
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ; Clark DJ; McFarlane LC
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ; Clark RA; Lipworth BJ
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A; Menzies D; Hopkinson P; McFarlane L; Lipworth BJ
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
    Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
    Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.
    Clearie KL; Williamson PA; Vaidyanathan S; Du Bois J; Nell H; Lipworth BJ
    Br J Clin Pharmacol; 2010 Jun; 69(6):637-44. PubMed ID: 20565455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
    Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR
    Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW; Wisniewski A; Honour J; Tattersfield AE
    Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the dose of fluticasone propionate inhaled by infants after bronchiolitis: Effect on urinary cortisol excretion.
    Wong J; Davies T; O'Callaghan C
    J Allergy Clin Immunol; 2002 Nov; 110(5):721-7. PubMed ID: 12417880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
    Grove A; Allam C; McFarlane LC; McPhate G; Jackson CM; Lipworth BJ
    Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination.
    Nair A; Clearie K; Menzies D; Meldrum K; McFarlane L; Lipworth BJ
    Pulm Pharmacol Ther; 2009 Aug; 22(4):305-10. PubMed ID: 19489129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.